Woodline Partners »

Immuneering Corp - Class A shares owned by Woodline Partners

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 150k 7.00

More positions owned by Woodline Partners

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
At&t (T)
Chubb (CB)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Keysight Technologies (KEYS)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Merus N V (MRUS)
Autodesk (ADSK)

View all positions for Woodline Partners

Top funds holding Immuneering Corp - Class A

FMR
Sanofi
Vanguard Group
ExodusPoint Capital Management
Logos Global Management
Citadel Advisors
BlackRock
Blue Owl Capital Holdings
Geode Capital Management
Monashee Investment Management
Burkehill Global Management
Iridian Asset Management
Southport Management
Marshall Wace
Diametric Capital

View all funds holding Immuneering Corp - Class A